Mineralys Therapeutics Inc. (MLYS) Statistics & Valuation Metrics - Stocknear

Mineralys Therapeutics In...

NASDAQ: MLYS · Real-Time Price · USD
37.10
-0.06 (-0.16%)
At close: Sep 12, 2025, 3:59 PM
36.40
-1.89%
After-hours: Sep 12, 2025, 05:04 PM EDT

Mineralys Therapeutics Statistics

Share Statistics

Mineralys Therapeutics has 66.3M shares outstanding. The number of shares has increased by 31.07% in one year.

66.3M
31.07%
3.81%
99.99%
42.81M
916
0.06%

Short Selling Information

The latest short interest is 7.41M, so 11.18% of the outstanding shares have been sold short.

7.41M
11.18%
14.69%
8.56

Valuation Ratios

The PE ratio is -3.36 and the forward PE ratio is -14.02. Mineralys Therapeutics's PEG ratio is -0.04.

-3.36
-14.02
0
218.1
3.12
-3.59
-0.04
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Mineralys Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 14.02, with a Debt / Equity ratio of 0.

14.02
14.02
0
n/a
n/a
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-3.49M
51
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by 215.48% in the last 52 weeks. The beta is -0.3, so Mineralys Therapeutics's price volatility has been lower than the market average.

-0.3
215.48%
17.45
14.07
86.83
1,413,959

Income Statement

n/a
-43K
-192.4M
-177.81M
-192.36M
-192.4M
-3.66
Full Income Statement

Balance Sheet

The company has 114.09M in cash and 0 in debt, giving a net cash position of 114.09M.

114.09M
n/a
n/a
-302.52M
335.72M
313.1M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -166.31M and capital expenditures -96K, giving a free cash flow of -166.41M.

-166.31M
-96K
-166.41M
-3.43
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

MLYS does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for MLYS is $46.5, which is 25.3% higher than the current price. The consensus rating is "Buy".

$46.5
25.3%
Buy
6
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

21.37
2